|
|
|
|
Search: 
Latin American Herald Tribune
Venezuela Overview
Venezuelan Embassies & Consulates Around The World
Sites/Blogs about Venezuela
Venezuelan Newspapers
Facts about Venezuela
Venezuela Tourism
Embassies in Caracas

Colombia Overview
Colombian Embassies & Consulates Around the World
Government Links
Embassies in Bogota
Media
Sites/Blogs about Colombia
Educational Institutions

Stocks

Commodities
Crude Oil
US Gasoline Prices
Natural Gas
Gold
Silver
Copper

Euro
UK Pound
Australia Dollar
Canada Dollar
Brazil Real
Mexico Peso
India Rupee

Antigua & Barbuda
Aruba
Barbados
Cayman Islands
Cuba
Curacao
Dominica

Grenada
Haiti
Jamaica
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines

Belize
Costa Rica
El Salvador
Honduras
Nicaragua
Panama

Bahamas
Bermuda
Mexico

Argentina
Brazil
Chile
Guyana
Paraguay
Peru
Uruguay

What's New at LAHT?
Follow Us On Facebook
Follow Us On Twitter
Most Viewed on the Web
Popular on Twitter
Receive Our Daily Headlines


  HOME | Science, Nature & Technology

Russia Signs Deal with India to Produce 100 Million Sputnik V Annual Doses

MOSCOW – The Russian Direct Investment Fund announced on Monday an agreement with the Indian Panacea Biotec to produce 100 million annual doses of the Sputnik V coronavirus vaccine.

The deal would allow RDIF to provide its international partners with the jab, the Russian sovereign fund said in a statement.

India is one of the first countries Russia has approached to manufacture the vaccine, approved by 59 countries.

“We are pleased to collaborate with RDIF to produce Sputnik V for global markets,” Managing Director of Panacea Biotec Rajesh Jain said according to the statement.

“Panacea Biotec brings decades of vaccine manufacturing and distribution know-how to scale-up Sputnik V supplies. Panacea Biotec will produce Sputnik V in its internationally accredited facilities complying to strict GMP standards and prequalified by WHO,” he added.

“Cooperation with Panacea Biotec is an important step to produce the vaccine in India and to supply our international partners around the world,” RDIF CEO Kirill Dmitriev said.

Last week, Dmitriev notified Russian President Vladimir Putin that India and South Korea are producing the vaccine and that the RDIF has signed agreements with a dozen countries.

The overseas-manufactured doses can be administered to Russians as well as other countries’ populations, Dmitriev added.

Russia is awaiting the arrival of a European Medicines Agency delegation which could conclude the vaccine approval process that started in early March.

 

Enter your email address to subscribe to free headlines (and great cartoons so every email has a happy ending!) from the Latin American Herald Tribune:

 

Copyright Latin American Herald Tribune - 2005-2021 © All rights reserved